How Does VENCLEXTA® (venetoclax tablets) Work? VENCLEXTA is designed to be completed in a set amount of time (12 months for previously untreated CLL SLL when combined with GAZYVA or about 24 months for previously treated CLL SLL when combined with rituximab), unlike some other oral therapies that you take until your disease progresses
VENCLEXTA® + GAZYVA® Dosing Schedule Discover the CLL SLL treatment dosing schedule for VENCLEXTA (venetoclax tablets) in combination with GAZYVA See full Prescribing and Safety information
What is VENCLEXTA® (venetoclax tablets)? | AML Treatment VENCLEXTA is a prescription medicine used in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who:
CLL (PU) Discussion Guide | VENCLEXTA® (venetoclax tablets) VENCLEXTA is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) It is not known if VENCLEXTA is safe and effective in children
A guide to CLL SLL treatment with VENCLEXTA What is VENCLEXTA? VENCLEXTA is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) It is not known if VENCLEXTA is safe and effective in children Safety Considerations • VENCLEXTA can cause serious side effects, including tumor lysis syndrome (TLS)